Literature DB >> 16373768

MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy.

Olivier Hauger1, Emma E Frost, Ruud van Heeswijk, Colette Deminière, R Xue, Yahsou Delmas, Christian Combe, Chrit T W Moonen, Nicolas Grenier, Jeff W M Bulte.   

Abstract

PURPOSE: To assess renal glomerular homing of intravenously injected superparamagnetic iron oxide (SPIO)-labeled mesenchymal stem cells (MSCs) at in vivo and ex vivo magnetic resonance (MR) imaging in an experimental rat model of mesangiolysis.
MATERIALS AND METHODS: Animal procedures were performed in accordance with protocols approved by Institutional Animal Care and Use Committee. Fourteen rats were divided into two groups: one pathologic (n = 10), with persistent mesangiolysis following simultaneous injection of OX-7 monoclonal antibody and puromycin aminonucleoside in which 10(7) SPIO- and DiI-labeled MSCs were injected, and one control (n = 4). In vivo and ex vivo MR imaging examinations were performed with 4.7- and 9.4-T spectrometers, respectively, and T2*-weighted sequences. In vivo signal intensity variations were measured in the liver and kidney before and 6 days after MSC injection. Intrarenal signal intensity variations were correlated with histopathologic data by means of colocalization of DiI fluorescence, alpha-actin, and Prussian blue stain-positive cells. Histologic differences between the glomerular homing of MSCs in different kidney portions were correlated to the areas of MR signal intensity decrease with nonparametric statistical tests.
RESULTS: On in vivo images, signal intensity measurements of pathologic kidneys following MSC injection did not show any signal intensity decrease (P = .7), whereas a 34% +/- 14 (mean +/- standard deviation) signal intensity decrease was observed in the liver (P < .01), where a substantial number of labeled cells were trapped. On ex vivo images, pathologic kidneys showed focal cortical (glomerular) areas of signal intensity loss, which was absent in controls. The areas of low signal intensity correlated well with alpha-actin and Prussian blue stain- and DiI-positive areas (P < .01), which indicates that MSCs specifically home to injured tissue. No MSCs were detected in the kidneys of control animals.
CONCLUSION: Intravenously injected MSCs specifically home to focal areas of glomerular damage and can be detected at ex vivo MR imaging. RSNA, 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16373768     DOI: 10.1148/radiol.2381041668

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  36 in total

1.  Labeling and Imaging of Stem Cells - Promises and Concerns.

Authors:  Richard Schäfer
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

2.  Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles.

Authors:  Ambros J Beer; Konstantin Holzapfel; Juliana Neudorfer; Guido Piontek; Marcus Settles; Holger Krönig; Christian Peschel; Jürgen Schlegel; Ernst J Rummeny; Helga Bernhard
Journal:  Eur Radiol       Date:  2008-02-20       Impact factor: 5.315

3.  Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia.

Authors:  Piotr Walczak; Jian Zhang; Assaf A Gilad; Dorota A Kedziorek; Jesus Ruiz-Cabello; Randell G Young; Mark F Pittenger; Peter C M van Zijl; Judy Huang; Jeff W M Bulte
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

Review 4.  Stem cell therapy: MRI guidance and monitoring.

Authors:  Dara L Kraitchman; Wesley D Gilson; Christine H Lorenz
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

Review 5.  Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging.

Authors:  Joshua M Thurman; Natalie J Serkova
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

Review 6.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

7.  Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study.

Authors:  Lian Li; Quan Jiang; Guangliang Ding; Li Zhang; Zheng Gang Zhang; Qingjiang Li; Swayamprava Panda; Mei Lu; James R Ewing; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-04       Impact factor: 6.200

8.  Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke.

Authors:  Olivier Detante; Samuel Valable; Florence de Fraipont; Emmanuelle Grillon; Emmanuel Luc Barbier; Anaïck Moisan; Josiane Arnaud; Christine Moriscot; Christoph Segebarth; Marc Hommel; Chantal Remy; Marie-Jeanne Richard
Journal:  Stem Cells Transl Med       Date:  2012-04-02       Impact factor: 6.940

9.  Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles.

Authors:  Richard Schäfer; Rüdiger Bantleon; Rainer Kehlbach; Georg Siegel; Jakub Wiskirchen; Hartwig Wolburg; Torsten Kluba; Frank Eibofner; Hinnak Northoff; Claus D Claussen; Heinz-Peter Schlemmer
Journal:  BMC Cell Biol       Date:  2010-04-06       Impact factor: 4.241

10.  In vivo MR imaging of magnetically labeled mesenchymal stem cells in a rat model of renal ischemia.

Authors:  Sung Il Jung; Seung Hyup Kim; Hyo-Cheol Kim; Kyu Ri Son; Se Young Chung; Woo Kyung Moon; Hoe Suk Kim; Jong-Sun Choi; Min Hoan Moon; Chang-Kyu Sung
Journal:  Korean J Radiol       Date:  2009-04-22       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.